{"id":93891,"date":"2019-10-28T14:41:22","date_gmt":"2019-10-28T14:41:22","guid":{"rendered":"https:\/\/clarivate.com\/compumark\/?p=47541"},"modified":"2024-12-16T12:39:01","modified_gmt":"2024-12-16T12:39:01","slug":"use-as-directed-navigating-the-complexities-of-pharmaceutical-trademarks","status":"publish","type":"post","link":"https:\/\/clarivate.com\/intellectual-property\/blog\/use-as-directed-navigating-the-complexities-of-pharmaceutical-trademarks\/","title":{"rendered":"Use as directed: Navigating the complexities of pharmaceutical trademarks"},"content":{"rendered":"<p>The global market for pharmaceutical products <a href=\"https:\/\/pharmaceuticalcommerce.com\/business-and-finance\/global-pharma-spending-will-hit-1-5-trillion-in-2023-says-iqvia\/\" target=\"_blank\" rel=\"noopener\">reached $1.2 trillion in 2018 \u2013 up $100 billion from the prior year.<\/a> This is projected to reach $1.5 trillion by 2021.<\/p>\n<p>New developments in biotechnology, nanotechnology and digital medicine are rapidly transforming the definition of pharma products. These trends are creating an ever-more crowded and complex brand landscape.<\/p>\n<p>As follow up to a <a href=\"https:\/\/clarivate.com\/compumark\/campaigns\/navigating-the-complexities-of-pharmaceutical-trademarks\/\">recent webinar<\/a> of the same title, <em>Use as directed<\/em> covers the regulatory complexities specific to the pharmaceutical trademark landscape. In this white paper, Maury M. Tepper, III of IP law firm Tepper &amp; Eyster, and Emmanuelle Ragon, Senior Legal Director and Head of Trade Marks at pharmaceutical company Sanofi, discuss the unique challenges facing pharmaceutical brands and strategies for developing and clearing pharma trademarks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The global market for pharmaceutical products reached $1.2 trillion in 2018 \u2013 up $100 billion from the prior year. This is projected to reach $1.5 trillion by 2021. New developments&#8230;<\/p>\n","protected":false},"author":2,"featured_media":265720,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[176,30,34,212,106],"class_list":["post-93891","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-brand","tag-compumark","tag-special-reports","tag-trademark-application","tag-trademark-clearance"],"acf":[],"lang":"en","translations":{"en":93891},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/93891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/comments?post=93891"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/93891\/revisions"}],"predecessor-version":[{"id":284099,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/93891\/revisions\/284099"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/media\/265720"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/media?parent=93891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/categories?post=93891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/tags?post=93891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}